Here are four key notes on the proposed changes to colorectal cancer treatment:
1. CMS is proposing to update the policy for covered colorectal screenings, adding coverage of computed tomography colonography and removing coverage of barium enema.
2. CMS is proposing to expand their complete CRC screening approach to include either a Medicare-covered, blood-based biomarker test or a noninvasive stool-based test, as well as expanding its coverage so that follow-on colonoscopy after a positive result would not aggregate beneficiary cost-sharing.
“This improves CRC screening access by encouraging patients to be screened without the fear of a surprise bill,” the post said.
3. CMS proposes removing the age-appropriate screening colonoscopy measure from the merit-based incentive program, which GI societies have pushed for this measure to “continue to be available for clinician reporting through MIPS,” the report said.
4. CMS proposes to codify its definition of CRC screening tests to include a follow-on screening colonoscopy after a positive blood-based colorectal cancer screening test. According to the report, this change aims to eliminate patient cost-sharing for facility fees.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.